IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cardiovascular Sciences Inc (CVSC)

Q3 2025 vs Q4 2025

Comparing institutional holders between quarters

Quarters

Q4 2025Q3 2025Q1 2019Q1 2016
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Steigerwald, Gordon & Koch Inc.
UNCHANGED
Shares200 from 200
Change0 (0%)
Value$0 ($0)
Filed 2026-01-23
Status
Steigerwald, Gordon & Koch Inc.
UNCHANGED20020000%$0$0$02026-01-23
Showing 1 of 1 institutions